Literature DB >> 15826836

ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages.

Chris L Lannon1, Poul H B Sorensen.   

Abstract

The ETV6-NTRK3 (TEL-TRKC) gene fusion was discovered by breakpoint analysis of the t(12;15)(p13;q25) translocation associated with congenital fibrosarcoma, a pediatric soft tissue malignancy. ETV6-NTRK3 (EN) encodes the sterile alpha motif oligomerization domain of the ETV6 (TEL) transcription factor linked to the protein tyrosine kinase domain of the neurotrophin-3 receptor NTRK3 (TRKC). The EN chimeric oncoprotein links to multiple signaling cascades including Ras-MAP kinase and PI3K-AKT through the IRS-1 adapter protein. Recent evidence indicates that a functional insulin-like growth factor 1 receptor axis and higher order polymer formation are essential for EN oncogenesis. EN has been detected in other malignancies, including secretory breast carcinoma. This chimeric oncoprotein is therefore unique in being expressed in tumors derived from multiple cell lineages.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15826836     DOI: 10.1016/j.semcancer.2005.01.003

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  47 in total

1.  The MECT1-MAML2 gene fusion and benign Warthin's tumor: is the MECT1-MAML2 gene fusion specific to mucuepidermoid carcinoma?

Authors:  Marta Winnes; Fredrik Enlund; Joachim Mark; Göran Stenman
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

2.  The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.

Authors:  Matthew J Martin; Nataliya Melnyk; Michelle Pollard; Mary Bowden; Hon Leong; Thomas J Podor; Martin Gleave; Poul H B Sorensen
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

Review 3.  Neonatal tumours.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2013-10-31       Impact factor: 1.827

4.  (R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-TRK Inhibitors.

Authors:  Ha-Soon Choi; Paul V Rucker; Zhicheng Wang; Yi Fan; Pamela Albaugh; Greg Chopiuk; Francois Gessier; Fangxian Sun; Francisco Adrian; Guoxun Liu; Tami Hood; Nanxin Li; Yong Jia; Jianwei Che; Susan McCormack; Allen Li; Jie Li; Auzon Steffy; AnneMarie Culazzo; Celine Tompkins; Van Phung; Andreas Kreusch; Min Lu; Bin Hu; Apurva Chaudhary; Mahavir Prashad; Tove Tuntland; Bo Liu; Jennifer Harris; H Martin Seidel; Jon Loren; Valentina Molteni
Journal:  ACS Med Chem Lett       Date:  2015-03-16       Impact factor: 4.345

5.  ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer.

Authors:  Rebecca J Leeman-Neill; Lindsey M Kelly; Pengyuan Liu; Alina V Brenner; Mark P Little; Tetiana I Bogdanova; Viktoria N Evdokimova; Maureen Hatch; Liudmyla Y Zurnadzy; Marina N Nikiforova; Ning J Yue; Miao Zhang; Kiyohiko Mabuchi; Mykola D Tronko; Yuri E Nikiforov
Journal:  Cancer       Date:  2013-12-10       Impact factor: 6.860

6.  Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis.

Authors:  Jinah Park; Junil Kim; Bora Park; Kyung-Min Yang; Eun Jin Sun; Cristina E Tognon; Poul H Sorensen; Seong-Jin Kim
Journal:  Oncogene       Date:  2018-02-02       Impact factor: 9.867

7.  SAM domain-dependent activity of PfTKL3, an essential tyrosine kinase-like kinase of the human malaria parasite Plasmodium falciparum.

Authors:  Abdirahman Abdi; Sylvain Eschenlauer; Luc Reininger; Christian Doerig
Journal:  Cell Mol Life Sci       Date:  2010-06-27       Impact factor: 9.261

8.  RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma.

Authors:  Robert C Smallridge; Ana-Maria Chindris; Yan W Asmann; John D Casler; Daniel J Serie; Honey V Reddi; Kendall W Cradic; Michael Rivera; Stefan K Grebe; Brian M Necela; Norman L Eberhardt; Jennifer M Carr; Bryan McIver; John A Copland; E Aubrey Thompson
Journal:  J Clin Endocrinol Metab       Date:  2013-12-02       Impact factor: 5.958

9.  A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report.

Authors:  Suning Chen; Stefan Nagel; Bjoern Schneider; Haiping Dai; Robert Geffers; Maren Kaufmann; Corinna Meyer; Claudia Pommerenke; Kenneth S Thress; Jiao Li; Hilmar Quentmeier; Hans G Drexler; Roderick A F MacLeod
Journal:  Cell Oncol (Dordr)       Date:  2017-11-08       Impact factor: 6.730

10.  Expression and function of the insulin receptor substrate proteins in cancer.

Authors:  Katerina Mardilovich; Shannon L Pankratz; Leslie M Shaw
Journal:  Cell Commun Signal       Date:  2009-06-17       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.